Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2009
12/02/2009CN101591319A Flavonoid derivatives and application thereof in preparing medicinal composition
12/02/2009CN101591300A Novel method for synthesizing lacosamide
12/02/2009CN101591231A Extraction technology for ammonium oxalate of bombyx batryticatus
12/02/2009CN101590236A Composition containing calcium antagonist and Statins and application thereof
12/02/2009CN101590217A Chinese medicinal composition for treating dysthymia and preparation method thereof
12/02/2009CN101590212A Chinese medicinal composition for treating mental diseases, preparation method, application and quality control thereof
12/02/2009CN101590207A Medicament for treating depression, and preparation method thereof
12/02/2009CN101590188A Chinese medicament for refreshing brain and benefiting intelligence and production technology thereof
12/02/2009CN101590163A Medicament for treating dementia and preparation method thereof
12/02/2009CN101590152A Preparation method of Bawei Chenxiang capsule
12/02/2009CN101590114A Medicament for treating multiple sclerosis and preparation method thereof
12/02/2009CN101590111A Medicinal composition for preventing birth defect and improving memory
12/02/2009CN101590097A Chinese herbal medicine prescription for reducing blood pressure and blood fat and improving sleep
12/02/2009CN101590094A Medicinal composition for preventing birth defects and improving memory
12/02/2009CN101590093A Medicinal composition for preventing birth defect and improving memory
12/02/2009CN101590090A Medicinal composition for preventing birth defect and improving memory
12/02/2009CN101590089A Medicinal composition for preventing birth defect and improving memory
12/02/2009CN101590086A Fructus akebiae extract, preparation and application thereof
12/02/2009CN101590083A Yinxingdamo oral preparation equivalent to similar intravenous preparation
12/02/2009CN101590066A Medicinal application of 1,6-diphosphate fructose in treating epilepsy complication and preventing epilepsy
12/02/2009CN101590065A Application of sibiricose A1, sibiricose A5 and tenuifoliside A in preparing tristimania treating products
12/02/2009CN101590062A Use of pregnane-diones or diols as neuropathic analgesic agents
12/02/2009CN101590060A Composition of ligustrazine and salvanolic acid B and application thereof
12/02/2009CN101590058A Medicinal composition containing dihydroergocryptine A mesylate
12/02/2009CN101590036A Application of epoxydiene taken as inhibitor of proinflammatory mediators
12/02/2009CN101590014A Process for preparing naloxone hydrochloride injection
12/02/2009CN101590008A Composition preparation of 24-methylene cycloartenol feruloyl esterase and purification process thereof
12/02/2009CN101589898A Multifunctional health care Chinese medicament pillow
12/02/2009CN101589834A Novel sobering-up beverage
12/02/2009CN100564517C Anti-glioma peptide of scorpion, preparation method and application thereof
12/02/2009CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/02/2009CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
12/02/2009CN100563714C Naloxone hydrochloride nano granule powder injection formulation and preparation thereof
12/02/2009CN100563707C Activation and inhibition of the immune system
12/02/2009CN100563688C Chinese medicine composition for treating drug addict and its suppository and application
12/02/2009CN100563656C Tamper-resistant oral opioid agonist
12/02/2009CN100563651C 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/02/2009CN100563648C Composition for oral administration containing alkylene dioxybenzene derivative
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/01/2009US7625925 Pyrazolo[1,5-a]pyridines and medicines containing the same
12/01/2009US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625904 Methods for the treatment of sleep disorders
12/01/2009US7625901 for treating migraine, headaches; 2-[(8S)-8-(3,5-Difluorophenyl)-6-oxo-7-azaspiro[4.5]dec-7-yl]-N-(2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2-yl)acetamide
12/01/2009US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/01/2009US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections
12/01/2009US7625861 Copolymer-1 improvements in compositions of copolymers
12/01/2009US7625713 Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide
12/01/2009US7625711 Screening method for the identification of a drug for the development of an agent for prevention and/or treatment of Alzheimer's disease
12/01/2009US7625562 Generation of cartilage using magnetizable particles
12/01/2009CA2521258C 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
12/01/2009CA2492196C Sulfotransferase inhibitors
12/01/2009CA2461100C 4-imidazolin-2-one compounds
12/01/2009CA2432121C Nitric oxide synthase inhibitor phosphate salt
12/01/2009CA2384718C Prostaglandin derivatives
12/01/2009CA2374317C Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators
12/01/2009CA2361802C O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
12/01/2009CA2315237C Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
11/2009
11/26/2009WO2009143507A2 Silent desensitizers of neuronal nachr and methods of use thereof
11/26/2009WO2009143470A1 Method for treating disease characterized by plaque
11/26/2009WO2009143445A1 Aza-beta-carbolines and methods of using same
11/26/2009WO2009143404A1 Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
11/26/2009WO2009143153A1 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009WO2009143064A2 Rice bran extracts for inflammation and methods of use thereof
11/26/2009WO2009143019A2 Method of treating peripheral nerve sensory loss using compounds having nicotinic acetylcholine receptor activity
11/26/2009WO2009142731A2 Niacin and nsaid combination therapy
11/26/2009WO2009142594A1 The use of 3beta-ethenyl, methyl, 3alpha-hydroxy-steroids for the treatment of cns disorders
11/26/2009WO2009142587A1 Method of treating anxious major depressive disorder
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009142195A1 Agent for induction/maintenance of remission
11/26/2009WO2009141736A2 Inhibition of emmprin to treat multiple sclerosis
11/26/2009WO2009141627A1 Treating niemann-pick disease type c and related disorders by elevating intracellular calcium
11/26/2009WO2009141625A1 Viral nucleic acid for the treatment of neurodegenerative disorders
11/26/2009WO2009141533A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/26/2009WO2009141532A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/26/2009WO2009141412A1 1,6-disubstituted 3-azabicyclo [3.1.0] hexane derivatives for use as triple reuptake inhibitors
11/26/2009WO2009141329A1 Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
11/26/2009WO2009141321A2 Tablettable chewing gums
11/26/2009WO2009140928A1 Dihydroindolinone derivatives
11/26/2009WO2009140859A1 Use of l-stepholidine (l-spd) derivatives
11/26/2009WO2009122301A3 Rasagiline mesylate particles and process for the preparation thereof
11/26/2009WO2009121155A3 Flavone containing compositions for treating mao associated disorders
11/26/2009WO2009120300A3 Method of treating degenerative diseases
11/26/2009WO2009118338A3 Use of a polyphenolic type compound for preventing or treating a polyglutamine expansion neurodegenerative disease
11/26/2009WO2009115547A8 Trisubstituted 1, 2, 4 -triazoles as nicotinic acetylcholine receptor modulators
11/26/2009WO2009102570A3 Treatments for neuropathy
11/26/2009WO2009102443A3 Octanoic acid formulations and methods of treatment using the same
11/26/2009WO2009083612A3 Flavonoid as means for the prophylaxis and treatment of neurodegenerative and other protein folding-aberration diseases
11/26/2009WO2009056833A3 Composition
11/26/2009WO2009043458A3 Use of oxytocin to treat many diseases
11/26/2009WO2009043457A3 Use of human hemokinin-1 and optionally oxytocin to treat diseases involving excessive angiogenesis
11/26/2009WO2009040024A3 Use of bim-23127 and optionally urodilatin as therapeutic agents eg for the treatment of m. tuberculosis infections
11/26/2009WO2009039981A3 Use of (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009039980A3 Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009039460A3 Co-administration of pimavanserin with other agents
11/26/2009WO2009033820A3 Use of saralasin and carbetocin in combination to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033783A3 Use of carbetocin to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033782A3 Use of a teprotide and optionally carbetocin to treat eg aids or idiopathic pulmonay fibrosis
1 ... 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 ... 1833